Table 3.

Summary of Type of Study Data Used, Patient Populations, and Study Settings across RE-AIM Domains for Articles Included in Systematic Scoping Review (n = 42)

	Study Data			Patient Population				Study Setting
	Quantitative	Qualitative	Mixed	Pediatric	Adult	All Ages	Other^*	Primary Care	Emergency Department	Inpatient	Multiple	Other^*
RE-AIM Category	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)
Reach (n = 7)	5 (71)^31–34,37	0	2 (29)^35,36	1 (14)³¹	1 (14)³⁵	5 (71)^{32–34,36,37}	0	5 (71)^31–34,36	1 (14)³⁷	0	1 (14)³⁵	0
Adoption (n = 13)	8 (61)^{34,38,39,42,46–49}	1 (8)⁴⁴	4 (30)^40,41,43,45	10 (77)^{38,40–45,47–49}	2 (15)^39,46	1 (8)³²	0	9 (69)^{34,38,39,41–44,46,48}	0	2 (15)^40,47	1 (8)⁴⁹	1 (8)⁴⁵
Implementation (n = 32)	13 (41)^{32,39,42,47,53–55,657,60–62,64,72}	9 (28)^{52,56,63,65–70}	10 (31)^{35,36,41,43,45,50,51,58,59,71}	12 (38)^{41–43,45,47,52,53,60,62,64,67}	10 (31)^{35,39,50,51,55,58,59,61,65,72}	8 (25)^{32,36,54,56,63,66,68,70}	2 (6)^69,71	22 (69) ^{32,36,39,41–43,53–58,60,63–70,72}	4 (13)^50,51,59,62	1 (3)⁴⁷	2 (6)^35,52	3 (9)^45,61,71
Maintenance (n = 1)	0	0	1 (100)⁴⁰	1 (100)⁴⁰	0	0	0	0	0	1 (100)⁴⁰	0	0
Total (n = 42)	21 (50)^{31–34,37–39,42,46–49,53–55,57,60–62,64,72}	10 (24)^{44,52,56,63,65–70}	11 (26)^{35,36,40,41,43,45,50,51,58,59,71}	18 (43)^{31,38,40–45,47–49,52,53,60,62,64,67}	11 (26)^{35,39,46,50,51,55,58,59,61,65,72}	11 (26)^{32–34,36,37,54,56,63,66,68,70}	2 (5)^69,71	29 (69)^{31–34,36,38,39,41–44,46,48,53–58,60,63–70,72}	5 (12)^{37,50,51,59,62}	2 (5)^40,47	3 (7)^35,49,52	3 (7)^45,61,71

↵* Other: one article on implementation took place in primary care but did not specify what patients were screened (Browne et al⁶⁹); another focused on Medicaid patients without any additional information provided on patient age or study setting (Chisolm et al⁷¹). Two articles took place in specialty settings (Power-Hays et al, adoption and implementation;⁴⁵ Godecker et al, implementation⁶¹).